| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 454,482 | 435,184 | 411,486 | 461,632 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 454,482 | 435,184 | 411,486 | 461,632 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 768,966 | 682,048 | 838,331 | 224,384 | | Non Recurring |
-
|
-
|
-
| 422,679 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (314,484) | (246,864) | (426,845) | (185,431) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (21,134) | | Earnings Before Interest And Taxes | (314,484) | (246,864) | (426,845) | (185,431) | | Interest Expense | 23,930 | 23,926 | 20,240 | 20,119 | | Income Before Tax | (338,414) | (270,790) | (447,085) | (205,550) | | Income Tax Expense | 1,421 | (86,230) | (173,738) | (88,924) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (339,835) | (184,560) | (273,347) | (113,274) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (339,835) | (184,560) | (273,347) | (113,274) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($339,835) | ($184,560) | ($273,347) | ($113,274) |
|
0.17% Nasdaq 
Income Statement
